References
1. Boiten HJ, van Domburg RT, Valkema R, Zijlstra F, Schinkel AF.
Dobutamine stress myocardial perfusion imaging: 8-year outcomes in
patients with diabetes mellitus. European Heart Journal-Cardiovascular
Imaging. 2016;17(8):871-6.
2. Zellweger MJ, Haaf P, Maraun M, Osterhues HH, Keller U, Müller-Brand
J, et al. Predictors and prognostic impact of silent coronary artery
disease in asymptomatic high-risk patients with diabetes mellitus.
International journal of cardiology. 2017;244:37-42.
3. Weinrauch L, D’elia J, Healy R, Gleason R, Takacs F, Libertino J, et
al. Asymptomatic coronary artery disease: angiography in diabetic
patients before renal transplantation: relation of findings to
postoperative survival. Annals of internal medicine. 1978;88(3):346-8.
4. Mitevska IP, Baneva N, Srbinovska E, Stojanovska L, Apostolopoulos V,
Bosevski M. Prognostic implications of myocardial perfusion imaging and
coronary calcium score in a Macedonian cohort of asymptomatic patients
with type 2 diabetes. Diabetes and Vascular Disease Research.
2017;14(4):285-94.
5. Fishman SL, Sonmez H, Basman C, Singh V, Poretsky L. The role of
advanced glycation end-products in the development of coronary artery
disease in patients with and without diabetes mellitus: a review.
Molecular Medicine. 2018;24(1):1-12.
6. Naito R, Miyauchi K. Coronary artery disease and type 2 diabetes
mellitus current treatment strategies and future perspective.
International heart journal. 2017:17-191.
7. Sanchez-Alcoholado L, Castellano-Castillo D, Jordán-Martínez L,
Moreno-Indias I, Cardila-Cruz P, Elena D, et al. Role of gut microbiota
on cardio-metabolic parameters and immunity in coronary artery disease
patients with and without type-2 diabetes mellitus. Frontiers in
microbiology. 2017;8:1936.
8. Kim T-H, Yang P-S, Uhm J-S, Kim J-Y, Pak H-N, Lee M-H, et al.
CHA2DS2-VASc score (congestive heart failure, hypertension, age≥ 75
[doubled], diabetes mellitus, prior stroke or transient ischemic
attack [doubled], vascular disease, age 65–74, female) for stroke
in Asian patients with atrial fibrillation: a Korean nationwide sample
cohort study. Stroke. 2017;48(6):1524-30.
9. Wiersma JJ, Verberne HJ, Trip MD, Wik L, van Eck-Smit BL, Piek JJ, et
al. Prevalence of myocardial ischaemia as assessed with myocardial
perfusion scintigraphy in patients with diabetes mellitus type 2 and
mild anginal symptoms. European journal of nuclear medicine and
molecular imaging. 2006;33(12):1468-76.
10. Morales DCV, Bhavnani SP, Ahlberg AW, Pullatt RC, Katten DM, Polk
DM, et al. Coronary risk equivalence of diabetes assessed by SPECT-MPI.
Journal of Nuclear Cardiology. 2019;26(4):1093-102.
11. Colon CM, Marshell RL, Roth CP, Farag AA, Iskandrian AE, Hage FG.
The prognostic value of myocardial perfusion imaging in patients with
type 2 myocardial infarction. Journal of Nuclear Cardiology. 2019:1-10.
12. Acampa W, Assante R, Zampella E, Petretta M, Cuocolo A. Myocardial
perfusion imaging for diabetes: Key points from the evidence and
clinical questions to be answered. Journal of Nuclear Cardiology.
2019:1-9.
13. Gimelli A, Achenbach S, Buechel RR, Edvardsen T, Francone M,
Gaemperli O, et al. Strategies for radiation dose reduction in nuclear
cardiology and cardiac computed tomography imaging: a report from the
European Association of Cardiovascular Imaging (EACVI), the
Cardiovascular Committee of European Association of Nuclear Medicine
(EANM), and the European Society of Cardiovascular Radiology (ESCR).
European heart journal. 2018;39(4):286-96.
14. Oki GCR, Pavin EJ, Coelho OR, Parisi MCR, Almeida RC, Etchebehere
ECSdC, et al. Myocardial perfusion scintigraphy in the detection of
silent ischemia in asymptomatic diabetic patients. Radiologia
Brasileira. 2013;46(1):7-14.
15. Cohn PF, Fox KM, of WtA, Daly C. Silent myocardial ischemia.
Circulation. 2003;108(10):1263-77.
16. Prior JO, Monbaron D, Koehli M, Calcagni M-L, Ruiz J, Delaloye AB.
Prevalence of symptomatic and silent stress-induced perfusion defects in
diabetic patients with suspected coronary artery disease referred for
myocardial perfusion scintigraphy. European journal of nuclear medicine
and molecular imaging. 2005;32(1):60-9.
17. Yamasaki Y, Nakajima K, Kusuoka H, Izumi T, Kashiwagi A, Kawamori R,
et al. Prognostic value of gated myocardial perfusion imaging for
asymptomatic patients with type 2 diabetes: the J-ACCESS 2
investigation. Diabetes Care. 2010;33(11):2320-6.
18. Scholte AJ, Schuijf JD, Kharagjitsingh AV, Dibbets-Schneider P,
Stokkel MP, van der Wall EE, et al. Prevalence and predictors of an
abnormal stress myocardial perfusion study in asymptomatic patients with
type 2 diabetes mellitus. European journal of nuclear medicine and
molecular imaging. 2009;36(4):567-75.
19. Kawasaki-Ogita Y, Hamamoto Y, Honjo S, Ikeda H, Wada Y, Nomura K, et
al. The limited usefulness of the treadmill test or a risk-guided
approach in screening for asymptomatic coronary heart disease in
Japanese patients with type 2 diabetes. Internal Medicine.
2012;51(24):3337-42.
20. Prior JO. Myocardial Perfusion Scintigraphy in Diabetes: Current
Status and Limitations. Integrating Cardiology for Nuclear Medicine
Physicians: Springer; 2009. p. 305-23.
21. Cosson E, Attali J, Valensi P. Markers for silent myocardial
ischemia in diabetes. Are they helpful? Diabetes & metabolism.
2005;31(2):205-13.
22. Al-Humaidi G, Sarikaya I, Elgazzar AH, Owunwanne A. Myocardial
perfusion abnormalities in asymptomatic type 2 diabetic patients.
Journal of the Saudi Heart Association. 2018;30(1):3-8.
23. Mohagheghie A, Ahmadabadi M, Hedayat D, Pourbehi M, Assadi M.
Myocardial perfusion imaging using technetium-99m sestamibi in
asymptomatic diabetic patients. Nuklearmedizin. 2011;50(01):3-8.
24. Wannamethee SG, Shaper AG, Whincup PH, Lennon L, Sattar N. Impact of
diabetes on cardiovascular disease risk and all-cause mortality in older
men: influence of age at onset, diabetes duration, and established and
novel risk factors. Archives of internal medicine. 2011;171(5):404-10.
25. Resl M, Vila G, Heinzl M, Luger A, Neuhold S, Prager R, et al.
Cardiovascular risk prediction in diabetes–changes in the prognostic
values of modern cardiovascular biomarkers in relation to duration of
diabetes mellitus. 2020.
26. Fox CS, Sullivan L, D’Agostino RB, Wilson PW. The significant effect
of diabetes duration on coronary heart disease mortality: the Framingham
Heart Study. Diabetes care. 2004;27(3):704-8.
27. Wu Y-T, Chien C-L, Wang S-Y, Yang W-S, Wu Y-W. Gender differences in
myocardial perfusion defect in asymptomatic postmenopausal women and men
with and without diabetes mellitus. Journal of Women’s Health.
2013;22(5):439-44.
28. Salehi Y, Fard-Esfahani A, Fallahi B, Aghahosseini F, Beiki D,
Emami-Ardekani A, et al. The myocardial perfusion scintigraphy in
asymptomatic diabetic patients. Iranian Journal of Nuclear Medicine.
2015;23(1):27-35.
29. Malik D, Mittal B, Sood A, Parmar M, Kaur G, Bahl A. Left
ventricular mechanical dyssynchrony assessment in long-standing type II
diabetes mellitus patients with normal gated SPECT-MPI. Journal of
Nuclear Cardiology. 2019;26(5):1650-8.